Accumulating evidence has suggested that neurotrophins participate in the pathophysiology of mood disorders. We have developed transgenic mice overexpressing the full-length neurotrophin-3 receptor TrkC (TgNTRK3) in the central nervous system. TgNTRK3 mice show increased anxiety-like behavior and enhancement of panic reaction in the mouse defense test battery, along with an increase in the number and density of catecholaminergic (tyrosine hydroxylase positive) neurons in locus coeruleus and substantia nigra. Furthermore, treatment of TgNTRK3 mice with diazepam significantly attenuated the anxiety-like behaviors in the plus maze. These results provide evidence for the involvement of TrkC in the development of noradrenergic neurons in the central nervous system with consequences on anxiety-like behavior and panic reaction. Thus, changes in TrkC expression levels could contribute to the phenotypic expression of panic disorder through a trophic effect on noradrenergic neurons in the locus coeruleus. Our results demonstrate that the elevated NT3-TrkC tone via overexpression of TrkC in the brain may constitute a molecular mechanism for the expression of anxiety and anxiety.
Recently, an accumulation of evidence has indicated that neurotrophins may be involved in the pathophysiology of mood disorders (Nestler et al., 2002; Castren, 2004a,b) . BDNF and NT-3 have been proposed as susceptibility genes for major depressive disorder and schizophrenia (Lin and Tsai, 2004; Tadokoro et al., 2004; Schumacher et al., 2005) and for other neuropsychiatric disorders (Ribases et al., 2005; Liu et al., 2005) . Administration of brainderived neurotrophic factor (BDNF-Mouse Genome Informatics) or neurotrophin-3 (NT3; NTF3-Mouse Genome Informatics) into the dentate gyrus or CA3 region of hippocampus causes antidepressantlike effects in the forced swim and learned helplessness tests (Shirayama et al., 2002) and activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects (Saarelainen et al., 2003) .
BDNF mouse mutants present higher anxiety levels when evaluated using the light/dark test and are hyperactive after exposure to stressors (Rios et al., 2001 ), although transgenic mice overexpressing the full-length neurotrophin receptor TrkB exhibit reduced anxiety (Koponen et al., 2004) . Furthermore, chronic administration of selective serotonin reuptake inhibitors and other antidepressants that suppress panic attacks, increase expression of TrkC and TrkB in the rat cerebral cortex (Nibuya et al., 1995; Castren, 2004a) . Recurrent panic attacks define panic disorder, a common and severe anxiety disorder of unknown etiology. Although several chromosomal regions and genes have been suggested to contribute to panic disorder, the phenotypic and genetic complexity of this disorder has precluded the finding of candidate genes (Knowles et al., 1998; Weissman et al., 2000; Crowe et al., 2001; Gratacos et al., 2001; Thorgeirsson et al., 2003) . It has been proposed that genetic variants of several candidate genes of neurotransmitter systems, mainly catecholaminergic, may con- 
